Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Health and Human Services (HHS) has unveiled a proposal to expand Medicare and Medicaid coverage to include weight loss drugs ...

New federal policies extend Medicaid to incarcerated youth and open the door for adult inmates to get coverage before they’re ...

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

A new proposal aims to expand Medicare and Medicaid coverage for anti-obesity medications (AOMs), potentially providing access to life-saving treatments.

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

On Tuesday night, Trump nominated Dr. Jay Bhattacharya to lead the National Institutes of Health, tapping an opponent of ...

The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

At a time when policy and practice is moving toward coverage of Food Is Medicine (FIM) as benefits in insurance programs, it ...

Under a new rule the Biden administration proposed on Tuesday, millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or ...